Automated Microbe Detection
LexaGene’s patented MiQLab System provides fully automated, rapid molecular testing at the point-of-need for accurate microbial detection. This technology has the potential to impact numerous industries, including biopharmaceutical manufacturing, veterinary diagnostics, human clinical diagnostics, food safety, and other markets.
Company
LexaGene Life Sciences develops automated molecular systems for rapid microbial detection to benefit numerous markets.
Product
LexaGene Life Sciences is developing a 2nd generation MiQLab System to specifically address the unmet market need for rapid microbial contamination testing.
Investors
Our experienced leadership team is driving company growth with a focus on innovation, pursuing unique market opportunities, and providing shareholder value.
Biopharmaceutical Manufacturing
Near-line screening for rapid microbial detection allows for data-driven manufacturing